Global Agrigenomics Market - Strategic Insights and Forecasts (2026-2031)

The global agrigenomics market, at a 9.79% CAGR, is expected to reach USD 9.381 billion in 2031, starting from USD 5.357 billion in 2025.

Key Highlights

Market Overview

Climate variability, pressure on global food systems, and the need to improve resource efficiency are changing purchasing priorities. Rather than relying solely on conventional breeding cycles, organizations increasingly combine genomic information with phenotypic evaluation to shorten variety development timelines and improve selection accuracy. International organizations, including the Food and Agriculture Organization (FAO) and CGIAR, continue to expand initiatives supporting conservation, characterization, and utilization of plant genetic resources, strengthening the long-term commercial foundation for agrigenomics technologies.

Technology adoption varies across the value chain. Large multinational seed companies and livestock genetics providers increasingly integrate next-generation sequencing (NGS), quantitative PCR (qPCR), and single nucleotide polymorphism (SNP) analysis into routine breeding operations, while universities, national agricultural research systems, and contract laboratories continue to account for a substantial share of research-oriented demand. Service providers benefit from customers seeking specialized sequencing, genotyping, and bioinformatics capabilities without investing in dedicated laboratory infrastructure.

Commercial value is distributed across instrument manufacturers, consumables suppliers, laboratory service providers, software developers, and breeding organizations. Revenue increasingly depends on long-term service relationships, data interpretation capabilities, regulatory compliance, and integration with breeding programs rather than laboratory testing alone. As genomic datasets expand and breeding decisions become increasingly data-driven, suppliers capable of combining laboratory expertise with scalable bioinformatics and analytical support are expected to strengthen their competitive position.

Key Market Indicators

Market Drivers

Expansion of genomic-assisted crop breeding programs.

Crop improvement programs increasingly rely on genomic information to shorten breeding cycles and improve selection accuracy under changing climatic conditions. The OECD notes that genomic selection enables breeders to identify desirable traits earlier than conventional breeding approaches, reducing time and resource requirements for variety development. CGIAR has further expanded collaborative breeding networks and genetic innovation programs supporting national agricultural research organizations across more than 130 countries. These initiatives create sustained demand for sequencing, SNP analysis, genotyping, and molecular marker services while encouraging suppliers to expand laboratory capacity, analytical software, and breeding support capabilities.

Growing investment in conservation and characterization of agricultural genetic resources.

Government agencies and international organizations continue investing in genetic resource conservation to strengthen future food security and climate resilience. FAO's Commission on Genetic Resources for Food and Agriculture supports global assessments, policy development, and conservation initiatives covering plant, animal, forest, and aquatic genetic resources. CGIAR genebanks distribute tens of thousands of germplasm samples annually for breeding and research, requiring extensive genomic characterization before commercial utilization. This environment supports recurring demand for sequencing, gene expression analysis, molecular marker development, and trait validation services across public and private breeding programs.

Increasing commercial adoption of sequencing technologies across agricultural laboratories.

Whole-genome sequencing has become more practical because of improved analytical performance, expanding computational capability, and wider laboratory experience. FAO recognizes whole-genome sequencing as an increasingly valuable platform for pathogen surveillance, food safety investigations, and broader genomic analysis. Similar technological improvements benefit agricultural breeding by enabling higher-resolution characterization of crop varieties and livestock populations. Instrument manufacturers and laboratory service providers continue investing in sequencing workflows, automation, and bioinformatics solutions that reduce turnaround times while supporting increasingly complex breeding decisions. The resulting expansion extends beyond research laboratories into commercial breeding organizations and specialized agricultural testing providers.

Market Restraints and Challenges

High bioinformatics requirements and limited availability of specialized expertise.

Generating genomic data has become faster and more affordable, but converting sequence information into breeding decisions remains resource intensive. Large sequencing datasets require specialized software, computing infrastructure, and skilled bioinformaticians capable of integrating genomic, phenotypic, and environmental information. Several technology providers, including Thermo Fisher Scientific and Illumina Inc., continue investing in automated analysis platforms, yet many public breeding institutes and smaller seed companies remain dependent on external service providers. The challenge affects project timelines, increases analytical costs, and limits adoption among organizations with limited computational resources.

Lengthy validation and regulatory approval processes for new genetic traits.

Commercial deployment of genomics-supported crop varieties and livestock traits extends well beyond laboratory validation. Breeding organizations must complete multi-season field evaluations, demonstrate trait stability, comply with national seed certification rules, and satisfy biosafety or variety registration requirements where applicable. Approval timelines differ across countries, creating additional complexity for multinational breeding programs. These requirements increase development costs and delay commercial returns, particularly for smaller developers with limited regulatory resources. Suppliers increasingly provide integrated testing, documentation, and regulatory support services to reduce approval risks, but compliance remains a structural feature of the market.

Dependence on high-quality biological samples and standardized reference datasets.

The reliability of agrigenomic analysis depends on sample quality, standardized laboratory protocols, and well-characterized reference genomes. Variability in sample collection, storage, DNA extraction, or sequencing quality can reduce analytical accuracy and require repeat testing. The challenge is more pronounced in developing agricultural markets where laboratory infrastructure and cold-chain logistics remain uneven. Service providers therefore invest heavily in quality management systems, laboratory accreditation, and standardized workflows to improve reproducibility. While these investments strengthen customer confidence, they also increase operating costs and raise barriers for new laboratories entering the market.

Budget constraints within publicly funded agricultural research programs.

Government research organizations remain important users of agrigenomic technologies, particularly in crop improvement, livestock conservation, and germplasm characterization. Funding cycles, however, are often influenced by national agricultural priorities and public budget allocations, creating uneven purchasing patterns for laboratory equipment and sequencing services. Capital-intensive technologies such as next-generation sequencing platforms may therefore experience slower adoption in institutions with limited funding despite clear scientific value. Commercial suppliers increasingly address this challenge through outsourced laboratory services, collaborative research projects, and shared sequencing facilities that reduce upfront investment requirements.

Major Segment Analysis

Next-Generation Sequencing (Technology)

Next-generation sequencing (NGS) represents the most commercially important technology segment because it supports a broad range of applications, including whole-genome sequencing, trait discovery, marker-assisted breeding, genomic selection, and biodiversity research. Unlike targeted molecular techniques, NGS generates high-resolution genomic information that enables breeders to identify complex traits associated with yield, disease resistance, drought tolerance, and nutritional quality. Improvements in sequencing throughput and workflow automation have expanded its use beyond academic research into commercial breeding and agricultural biotechnology.

Purchasing decisions increasingly extend beyond instrument performance. Seed companies, livestock genetics providers, and agricultural research organizations evaluate bioinformatics capability, workflow scalability, data security, turnaround time, and long-term technical support before selecting technology partners. Companies such as Illumina Inc., Thermo Fisher Scientific, and Tecan Trading AG compete by integrating sequencing platforms with automated sample preparation, analytical software, and laboratory services. Although qPCR and SNP-based assays remain preferred for routine validation because of lower costs and faster processing, NGS continues to receive the highest investment for comprehensive genomic analysis and long-term breeding programs.

Regional Analysis

North America benefits from a mature agricultural biotechnology ecosystem, extensive commercial breeding activity, and strong investment in genomics research. The United States accounts for much of the regional demand through public institutions, multinational seed developers, livestock genetics companies, and agricultural biotechnology firms. Public funding from agencies such as the U.S. Department of Agriculture continues to support genomic research, while commercial laboratories increasingly integrate sequencing, molecular diagnostics, and bioinformatics into breeding operations. Buyers typically prioritize analytical accuracy, workflow automation, regulatory compliance, and scalable laboratory capacity.

European demand is supported by established plant breeding programs, livestock improvement initiatives, and collaborative research funded through regional scientific programs. Countries including Germany, France, the Netherlands, and the United Kingdom maintain strong research capabilities in crop genetics and molecular breeding. Regulatory oversight remains more stringent than in several other regions, requiring extensive documentation and validation before commercial deployment of genetically related technologies. These conditions encourage investment in high-quality laboratory services and traceability solutions while extending product development timelines.

Asia Pacific presents one of the broadest opportunities because governments continue investing in food security, crop productivity, and agricultural modernization. China, India, Japan, South Korea, and Australia have expanded genomic research capabilities through national agricultural research institutes and university collaborations. Commercial demand increasingly originates from hybrid seed development, rice and wheat improvement, horticultural breeding, and livestock productivity programs. Adoption remains uneven across the region, reflecting differences in research funding, laboratory infrastructure, and technical expertise, yet public investment continues to strengthen long-term demand.

South America remains an important agricultural production region where soybean, maize, sugarcane, and livestock industries support increasing use of molecular breeding tools. Brazil and Argentina account for much of the regional activity because of their export-oriented agricultural sectors and established crop research institutions. Investment in genomic testing is rising, although dependence on imported laboratory equipment and fluctuations in public research funding can influence purchasing decisions. International technology providers frequently collaborate with regional laboratories to improve technical capability and expand service availability.

Competitive Landscape

Competition in the agrigenomics market is technology-driven and service-intensive rather than purely price-based. Instrument manufacturers, sequencing platform developers, laboratory service providers, and agricultural genomics specialists compete by expanding analytical capabilities, improving workflow efficiency, and offering integrated laboratory and bioinformatics solutions. Long-term customer relationships are supported through technical support, regulatory documentation, application-specific expertise, and scalable data analysis rather than laboratory testing alone.

Thermo Fisher Scientific, Illumina Inc., and Tecan Trading AG strengthen their market position through sequencing platforms, automation technologies, and analytical software. Eurofins, Neogen Corporation, and AgriGenome Labs Pvt Ltd compete by expanding specialized testing services, genotyping, trait validation, and molecular diagnostics. Meanwhile, Zoetis Inc. extends livestock genomics capabilities through precision breeding and animal health solutions, while companies such as Daicel Arbor Biosciences, Galseq, and Biogenetic Services Inc. address niche sequencing and genomic analysis requirements. High capital investment, technical expertise, laboratory accreditation, and established customer trust continue to raise barriers for new entrants.

Recent Developments

• March 2026: Neogen agreed to sell its Genomics business to Zoetis. The transaction strengthens Zoetis' livestock genetics portfolio, enhancing genomic testing and breeding capabilities for cattle and other production animals while sharpening Neogen's strategic business focus.

• January 2026: seqWell launched the AgriPrep Library Prep Kit. Designed specifically for agrigenomics, the kit enables affordable, scalable low-coverage whole-genome sequencing for plant and animal breeding, supporting genomic selection, parentage testing, trait mapping, and variant discovery.

• October 2025: Complete Genomics expanded its agricultural sequencing portfolio at ASHG 2025. The company showcased new sequencing products, platform enhancements, and research collaborations that broadened high-throughput genomic analysis capabilities applicable to plant and livestock genomics research.

• July 2025: Miraterra acquired Trace Genomics' technology and products. The acquisition combined soil genomics, analytical laboratory capabilities, intellectual property, and Raman spectroscopy technologies to accelerate integrated soil-health insights supporting precision agriculture and crop improvement.

Regulatory and Policy Environment

Agrigenomics operates within a regulatory framework that combines agricultural policy, biotechnology oversight, seed certification standards, food safety requirements, and biodiversity conservation. Regulatory obligations differ by country, particularly where genomic technologies intersect with genetically modified organisms, genome editing, or commercial variety registration. Companies must therefore adapt testing protocols, documentation, and product development strategies to national regulatory requirements rather than relying on a single global compliance model.

The Food and Agriculture Organization continues to support conservation and sustainable use of plant and animal genetic resources through international guidance and technical programs. The Organisation for Economic Co-operation and Development develops internationally recognized seed schemes and varietal certification frameworks that facilitate cross-border trade and improve confidence in certified planting material. In several markets, biosafety authorities and national seed certification agencies require extensive field validation, molecular characterization, and documentation before new varieties reach commercial production.

Data governance is becoming increasingly important as breeding organizations generate larger genomic datasets. Laboratory accreditation, sample traceability, quality assurance, and secure management of genetic information have become important purchasing criteria, particularly for multinational breeding programs and collaborative research initiatives. These requirements encourage continued investment in laboratory quality systems, standardized analytical workflows, and secure bioinformatics infrastructure.

Outlook and Strategic Implications

Commercial demand during the 2026-2031 period is expected to be shaped by the increasing integration of genomics into routine breeding decisions rather than by research activity alone. Crop improvement programs, livestock genetics, molecular diagnostics, and seed quality testing are likely to remain the largest sources of laboratory demand as agricultural producers seek measurable improvements in productivity, disease resistance, climate resilience, and resource efficiency. Continued investment by governments and international agricultural organizations in genetic resource conservation will also strengthen the long-term pipeline for genomic analysis services.

Several strategic priorities are expected to influence competitive positioning over the forecast period:

• Technology providers will continue integrating sequencing platforms with automation, cloud-based bioinformatics, and decision-support software to reduce laboratory turnaround times.

• Laboratory service providers are likely to expand outsourced genomic testing as customers seek specialized expertise without investing in high-cost sequencing infrastructure.

• Seed developers and livestock breeding companies will increasingly prioritize genomic selection tools that shorten breeding cycles and improve trait prediction accuracy.

• Public research organizations are expected to strengthen collaborations with commercial laboratories and technology suppliers to improve access to advanced sequencing and analytical capabilities.

• Investors are likely to favor companies combining laboratory technologies, bioinformatics, and long-term service contracts, as recurring analytical services generally provide more stable revenue than standalone equipment sales.

The market's commercial performance will depend less on the availability of sequencing technologies than on organizations' ability to convert genomic information into practical breeding decisions. Suppliers offering integrated laboratory services, advanced data interpretation, regulatory support, and scalable genomic workflows are expected to strengthen their competitive position as agrigenomics becomes a routine component of agricultural innovation and food production strategies.

Agrigenomics Market Scope: